Around 4,500 women in the UK will be eligible for treatment with Gedeon Richter's once-daily oral therapy Ryeqo, after NICE backed the GnRH antagonist to treat heavy menstrual bleeding associated with ...
The findings, published in two studies, show that SN stimulates the growth and activity of neurons that control reproduction, and does so through a previously unknown delivery mechanism: tiny ...
Theramex has opted out of the U.K.’s self-regulatory program for pharma ma | Theramex has opted out of the U.K.’s ...
Kisspeptin sits at the center of one of the most critical control systems in human reproduction, but it’s still widely ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Kisspeptin‑10 (KP‑10) is a short, bioactive cleavage product of the KiSS1 precursor peptide that has gained prominence as a ...
SkinJect™ , a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome , a rare autosomal dominant disease ...
As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.
The combination of letrozole with a GnRH antagonist protocol in patients with expected POR (Patient-Oriented Strategies Encompassing Individualized Oocyte Number groups 3 and 4) reduced the mean total ...
SkinJect™, a novel localized immuno-oncology precision product focused on non-melanoma skin diseases, especially basal cell carcinoma (BCC) and Gorlin Syndrome, a rare autosomal dominant disease also ...
Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results